New insights into the perception of coffee taste - genetic predisposition plays a role
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Jun-2025 13:10 ET (26-Jun-2025 17:10 GMT/UTC)
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson’s disease. Researchers identified genetic factors in progression and FDA-approved drugs that can potentially be repurposed for PD treatment.
The npj Parkinson’s Disease report uses an approach called “systems biology,” which uses AI to integrate and analyze multiple different forms of information from genetic, proteomic, pharmaceutical and patient datasets to identify patterns that may not be obvious from analyzing one for of data on its own.
A global team of scientists has made a groundbreaking discovery of a new skeletal tissue known as “lipocartilage,” offering immense potential for regenerative medicine and tissue engineering.
Among the researchers contributing to this work is Dr. Richard Prince, an assistant professor at East Tennessee State University with a Ph.D. in biomedical engineering.
Published in Science, the study reveals that lipocartilage, found in the ears, nose and throat of mammals, is composed of fat-filled cells called lipochondrocytes. These cells provide super-stable internal support, allowing the tissue to remain both soft and elastic – similar to the qualities of bubble wrap.